Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Where are they at with their COVID treatment plans?

<< Previous

Bullboard Posts

Next >>

Comment by greaterfoolFredon Nov 28, 2021 12:07pm

202 Views

Post# 34173532

RE:RE:RE:RE:RE:Where are they at with their COVID treatment plans?

Yes Longholder99 and Wildbird, you guys are right about the press release, but I think it was a bit optimistic. If you make a vaccine by killing a whole virus, then it may be more effective against variants than a mrna vaccine that only makes the spike protein. But early data (which I hope is wrong) says that the Astrazenica vaccine, which is from whole virus, doesn't seem to be working very well against the O variant. What we need is a therapy, ie. 1433 as a drug.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing